Evidence map›Paper›PMID 40723250›Full record

ReviewCancers2025

The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review.

Yuta Yamada, Naoki Kimura, Kazuki Maki, Yuji Hakozaki, Fumihiko Urabe, Shoji Kimura, Tetsuya Fujimura, Satoshi Inoue, Haruki Kume

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Roles of the E3 Ubiquitin Ligase TRIM47 in Inflammation, Organ Injury, and Cancer.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  3. Article
  4. LncRNAFrontiers in oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuta YamadaDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan.
Naoki KimuraDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan.
Kazuki MakiDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan.
Yuji HakozakiDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan.
Fumihiko UrabeDepartment of Urology, The Jikei University Daisan Hospital, Komae-Shi 201-8601, Tokyo, Japan.ORCID 0000-0002-2599-8183
Shoji KimuraToneri Urology Clinic, Adachi-Ku, Tokyo 121-0831, Japan.
Tetsuya FujimuraDepartment of Urology, Jichi Medical University, Shimotsuke-Shi 329-0498, Tochigi, Japan.
Satoshi InoueSystems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology (TMIG), Itabashi-Ku, Tokyo 173-0015, Japan.ORCID 0000-0003-1247-3844
Haruki KumeDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan.

Funding

Yamaguchi Endocrine Research Association No number (2023 grant on urological field)
6 · The paper itself

Abstract

We aimed to investigate the roles of tripartite motif (TRIM) proteins in urological cancers.

Indexed as

bladder cancerkidney cancerprostate cancertesticular cancerTRIMtripartite motif proteinubiquitinationurological cancer

Identifiers

PMID40723250
PMCPMC12294046

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.